People · Operator
Named in public records as an officer, director or promoter · active 2013–2015 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aerin Medical Inc. | — | Healthtech | Series C | $145.2M | $243.2M | 2015 |
| StemBioSys Inc. | — | Biotechnology | Series A | $9.9M | $43.8M | 2013 |
Peter Savas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Savas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Ryan Drant | 1 | 24 |
| Robert S Langer | 1 | 14 |
| Nael Kassar | 1 | 11 |
| Greg Garfield | 1 | 8 |
| Greg Young | 1 | 8 |
| John White | 1 | 7 |
| Paul Castella | 1 | 6 |
| Steven Davis | 1 | 6 |
| David Thrower | 1 | 5 |
| Kevin Reilly | 1 | 5 |
| William Facteau | 1 | 5 |
| Karen Long | 1 | 4 |
| Scott Wolf | 1 | 4 |
| Gregory S. Young | 1 | 3 |
| Jean Cheever | 1 | 2 |
| Derrick Sung | 1 | 2 |
| Valeska Schroeder | 1 | 2 |
| John Feik | 1 | 2 |
| Greg S. Garfield | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.